Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.
Although the pathogenic role of interleukin-13 (IL-13) is a key for atopic dermatitis (AD), the mechanism of IL-13 production in AD remains unclear. To investigate the role of the T-cell receptor Vbeta (TCR Vbeta) haplotype in the development of dermatitis and the production of IL-13 in the naturally occurring dermatitis model by staphylococcal enterotoxin C (SEC)-producing Staphylococcus aureus, we raised DS-Nh mice harbouring the TCR Vbeta(a) haplotype with a central deletion in the TCRBV gene segments, including TCR Vbeta8S2. Observation and histopathological analysis of the two mouse substrains with spontaneous dermatitis indicated that later onset and weaker severity of AD-like dermatitis were identified in mice with TCR Vbeta(a) compared to those with TCR Vbeta(b). Immunohistochemical examination revealed the infiltration of a large number of CD4-bearing T cells in the skin lesions in mice with TCR Vbeta(b) but not in those with TCR Vbeta(a). Interestingly, much lower levels of serum IL-13 were detected in mice with the TCR Vbeta(a) than in those with the TCR Vbeta(b) haplotype. In vitro, synthetic ligands (Pam(2)CSK4) of toll-like receptor 2 (TLR2) synergistically produced IL-13 with SEC in splenocytes of mice with TCR Vbeta(b) but not of those with TCR Vbeta(a), and natural killer T cells were essential for this synergism. Our findings suggested that this TCR Vbeta-haplotype-dependent synergism with TLR2 plays an important role in the development of AD-like dermatitis in DS-Nh mice.
Yoshioka
Takeshi
T
Shionogi Discovery Research Laboratories, Shionogi & Co. Ltd, Osaka, Japan. takeshi.yoshioka@shionogi.co.jp
Imura
Kinichi
K
Hikita
Ichiro
I
Hirasawa
Tsutomu
T
Sakata
Tsuneaki
T
Matsutani
Takaji
T
Horikawa
Tatsuya
T
Arimura
Akinori
A
D000818:Animals; D049109:Cell Proliferation; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism; D003876:Dermatitis, Atopic / Q000235:genetics* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D004768:Enterotoxins / Q000276:immunology*; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D018793:Interleukin-13 / Q000096:biosynthesis*; D007694:Killer Cells, Natural / Q000276:immunology; D008024:Ligands; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D010457:Peptidoglycan / Q000276:immunology; D016133:Polymerase Chain Reaction / Q000379:methods; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics* / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013211:Staphylococcus aureus; D018089:Superantigens / Q000276:immunology; D051195:Toll-Like Receptor 2 / Q000276:immunology
D004768:Enterotoxins; D018793:Interleukin-13; D008024:Ligands; D010457:Peptidoglycan; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; C034959:enterotoxin C, staphylococcal; D003094:Collagen